Patent intelligence · US
US 11701307
Organic-inorganic composite particles, manufacturing method therefor, and cosmetic
Organic-inorganic composite particles, manufacturing method therefor, and cosmetic
Patent details — US 11701307
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 18, 2023
- Expiration
- Jul 13, 2043
- Applicant
- JGC Catalysts and Chemicals Ltd.
- Claims
- 10
- CPC classes
- A61K, A61K2800/412, A61K8/025, A61K8/0279
Quick answer
US 11701307 (Organic-inorganic composite particles, manufacturing method therefor, and cosmetic) is held by JGC Catalysts and Chemicals Ltd.. Status: granted. Granted Jul 18, 2023. Expires Jul 13, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- JGC Catalysts and Chemicals Ltd.
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K2800/412, A61K8/025, A61K8/0279, A61K8/25, A61K8/731
More from JGC Catalysts and Chemicals Ltd.
Related pharmaceutical patents in our USPTO index.
-
US 11806421
Porous-cellulose particles and production method thereof, and cosmetic
granted -
US 11491212
Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B
granted -
US 11401513
Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 11384062
Deuterated (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide
granted -
US 11266724
Modified factor VII polypeptides for subcutaneous administration and on-demand treatment
granted -
US 11203749
Factor VII polypeptides that are modified and uses thereof
granted -
US 11020326
Hollow particles and cosmetic
granted
Related coverage
Frequently asked questions
What is US patent 11701307?
US 11701307 (Organic-inorganic composite particles, manufacturing method therefor, and cosmetic) is held by JGC Catalysts and Chemicals Ltd.. Status: granted. Granted Jul 18, 2023. Expires Jul 13, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11701307?
JGC Catalysts and Chemicals Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 61 pharmaceutical patents for this assignee.
When does US 11701307 expire?
Our index shows an expiration date of Jul 13, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.